Close Menu

Seattle Biomedical Research Institute

Leroy Hood called the bill short-sighted and said that over the long-term it could potentially reduce the attractiveness of starting up companies in the Seattle area.

SBRI is hoping to increase its staff to 400 in 2010, and it expects to conduct research to complement the systems biology work and informatics developed by the Institute for Systems Biology.

Shire Owings Mills (Md.) Plant, Alexandria Real Estate Equities, Takeda Pharmaceutical, Wareham Development, PATH, Fall River (Mass.) Executive Park, University of Massachusetts/Dartmouth Bioprocessing Facility, Silicon Border, Sapphire Engineering, Campanelli Business Park, University of California-Davis M.I.N.D., Institute, Doe & Ingalls of North Carolina, Covaris, Life Technologies, BioMed Realty Trust, Shasun Pharma Solutions

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.